Bristol Myers (BMY) Gets US Nod for First New Schizophrenia Drug …
WEB1 day ago · Bristol Myers Squibb Co.gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh avenue of treatment for millions with the serious mental disorder.
Bristol Myers wins US FDA approval for new type of schizophrenia …
WEB1 day ago · The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.
F.D.A. Approves the First New Schizophrenia Drug in Decades
WEB1 day ago · The Food and Drug Administration on Thursday approved the first novel antipsychotic treatment in decades, a drug developed to treat schizophrenia without disabling side effects like weight gain.
Bristol Myers Squibb - U.S. Food and Drug Administration …
WEB14 hours ago · PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
FDA approves Bristol Myers Squibb's schizophrenia drug
WEB1 day ago · The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in...
A new kind of drug for schizophrenia promises fewer side effects
WEB5 hours ago · Steve Belkowitz/Bristol Myers Squibb. For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by...
FDA approves Bristol Myers Squibb's new schizophrenia drug
WEB10 hours ago · The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the ...
FDA approves 1st new drug for schizophrenia in more than 30 years
WEB1 day ago · Cobenfy, manufactured by Bristol Myers Squibb, combines two drugs, xanomeline and trospium chloride, and is taken as a twice-daily pill. In clinical trials, this combination helped manage symptoms such as hallucinations, delusions, and disorganized thinking, which are common in schizophrenia.
Bristol Gets Nod for First New Schizophrenia Drug Type in Years
WEBBristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh avenue of treatment for millions with the serious mental disorder.
FDA Approves the First New Schizophrenia Drug in Decades
WEB12 hours ago · Lenkowsky says Bristol Myers Squibb is conducting a trial studying Cobenfy in combination with dopamine-based medications that will yield results in about a year.
Skip to content